Home › Glioma › California › Orange
Glioma clinical trials in Orange, CA
6 studies for Glioma are looking for participants at sites in and around Orange (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RecruitingPhase 1/2
- Children's Hospital of Orange County, Orange
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
RecruitingPhase 1
- Children's Hospital Orange County (CHOC), Orange
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
RecruitingPhase 4
- UCI Irvine Health, Orange
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
RecruitingPhase 1
- University of California Irvine, Orange
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
RecruitingEarly phase 1
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
RecruitingPhase 1
- Children's Health Orange County (CHOC), Orange
Glioma trials in other cities
- New York City, NY25 studies
- Houston, TX23 studies
- Boston, MA20 studies
- Washington, DC19 studies
- Philadelphia, PA16 studies
- Miami, FL15 studies
- Columbus, OH15 studies
- San Francisco, CA14 studies
- Chicago, IL13 studies
- Durham, NC12 studies
- Seattle, WA11 studies
- Aurora, CO10 studies
Other studies in Orange
- Non-Small Cell Lung Cancer25 studies
- Metastatic Cancer20 studies
- Colorectal Cancer16 studies
- Ovarian Cancer16 studies
- Pancreatic Cancer15 studies
- Lung Cancer14 studies
- Cancer (all types)14 studies
- Melanoma14 studies
- Prostate Cancer14 studies
- Breast Cancer14 studies
- Liver Cancer (Hepatocellular Carcinoma)14 studies
- Stomach Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.